Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

B-cell transcription factor expression and immunoglobulin gene rearrangement frequency in acute myeloid leukemia with t(8;21)(q22;q22).

Johnson RC, Ma L, Cherry AM, Arber DA, George TI.

Am J Clin Pathol. 2013 Sep;140(3):355-62. doi: 10.1309/AJCPFBCFXP94AKWJ.

PMID:
23955454
3.

Expression of B cell-specific activator protein/PAX5 in acute myeloid leukemia with t(8;21)(q22;q22).

Valbuena JR, Medeiros LJ, Rassidakis GZ, Hao S, Wu CD, Chen L, Lin P.

Am J Clin Pathol. 2006 Aug;126(2):235-40.

PMID:
16891199
4.

PAX5 expression in acute leukemias: higher B-lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia.

Tiacci E, Pileri S, Orleth A, Pacini R, Tabarrini A, Frenguelli F, Liso A, Diverio D, Lo-Coco F, Falini B.

Cancer Res. 2004 Oct 15;64(20):7399-404.

5.

Prognostic value of lymphocyte surface markers in acute myeloid leukemia.

Ball ED, Davis RB, Griffin JD, Mayer RJ, Davey FR, Arthur DC, Wurster-Hill D, Noll W, Elghetany MT, Allen SL, et al.

Blood. 1991 May 15;77(10):2242-50.

6.

Aberrant expression of CD19 in AML with t(8;21) involves a poised chromatin structure and PAX5.

Walter K, Cockerill PN, Barlow R, Clarke D, Hoogenkamp M, Follows GA, Richards SJ, Cullen MJ, Bonifer C, Tagoh H.

Oncogene. 2010 May 20;29(20):2927-37. doi: 10.1038/onc.2010.56. Epub 2010 Mar 8.

PMID:
20208555
7.

Diagnostic utility of the B-cell lineage markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasms.

Adams H, Liebisch P, Schmid P, Dirnhofer S, Tzankov A.

Appl Immunohistochem Mol Morphol. 2009 Mar;17(2):96-101. doi: 10.1097/PAI.0b013e3181845ef4.

PMID:
18838917
8.
9.
10.

Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma.

García-Cosío M, Santón A, Martín P, Camarasa N, Montalbán C, García JF, Bellas C.

Mod Pathol. 2004 Dec;17(12):1531-8.

12.
13.

CD19 expression in acute leukemia is not restricted to the cytogenetically aberrant populations.

Francis J, Dharmadhikari AV, Sait SN, Deeb G, Wallace PK, Thompson JE, Wang ES, Wetzler M.

Leuk Lymphoma. 2013 Jul;54(7):1517-20. doi: 10.3109/10428194.2012.754096. Epub 2013 Jan 3.

PMID:
23193950
14.

Aberrant lymphoid antigen expression in acute myeloid leukemia in Saudi Arabia.

El-Sissy AH, El-Mashari MA, Bassuni WY, El-Swaayed AF.

J Egypt Natl Canc Inst. 2006 Sep;18(3):244-9.

15.

Lymphoid-associated antigen expression by acute myeloid leukemia.

Launder TM, Bray RA, Stempora L, Chenggis ML, Farhi DC.

Am J Clin Pathol. 1996 Aug;106(2):185-91.

PMID:
8712171
17.

[Abnormal expression of cCD79a/cCD22 in acute myeloid leukemia with t (8;21)].

He GS, Zhou L, Wu DP, Xue YQ, Zhu MQ, Liu DD, Sun AN, Jin ZM, Qiu HY, Miao M, Tang XW, Fu ZZ, Ma X, Wang XL.

Zhonghua Xue Ye Xue Za Zhi. 2006 Mar;27(3):187-9. Chinese.

PMID:
16792922
18.

[Immunophenotypic analysis of acute myeloid leukemia with t(8;21)].

Fan L, Wu YJ, Zhang JF, Qiu HR, Qiao C, Wang R, Yang H, Xu W, Li JY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Dec;18(6):1410-3. Chinese.

PMID:
21176340
19.
20.

Lineage-inappropriate PAX5 expression in t(8;21) acute myeloid leukemia requires signaling-mediated abrogation of polycomb repression.

Ray D, Kwon SY, Tagoh H, Heidenreich O, Ptasinska A, Bonifer C.

Blood. 2013 Aug 1;122(5):759-69. doi: 10.1182/blood-2013-02-482497. Epub 2013 Apr 24.

Supplemental Content

Support Center